Innovative Journal of Medical and Health Sciences


Open Access & Peer Reviewed
Advanced Search
  • Current
  • Archives
  • Publisher Information
  • Peer Review Policy
  • About
    • About the Journal
    • Submissions
    • Journal Reviewers
    • Editorial Policy
    • Manuscript Processing Time
    • Publication Charges
    • Editorial Team
    • Announcements
  • Register
  • Login
  1. Home
  2. Archives
  3. Vol. 10 No. 06 (2020): Innovative Journal of Medical and Health Science
  4. Research Articles

Assessing the effect of idebenone in LHON by silent-MT 7T-MRI of the optic nerve requires appropriate study designs

  • Josef Finsterer, MD, PhD*
  • Josef Finsterer, MD, PhD*
     Krankenanstalt Rudolfstiftung, Messerli Institute, Austria

    Search for the other articles from the author in:
    Google Scholar | PubMed | BMJ Journal

Cite this:
[1]
Josef Finsterer, MD, PhD*, “Assessing the effect of idebenone in LHON by silent-MT 7T-MRI of the optic nerve requires appropriate study designs”, ijmhs, vol. 10, no. 06, pp. 918–919, Jun. 2020.
© 2022 Interactive Protocols
RIGHTS & PERMISSIONS
Article Views
290
Altmetric
1
Citations
-
LEARN ABOUT THESE METRICS
Share
   PDF      PubMed      DOAJ  

Abstract

With interest we read the article by Grochowski et al.
about an investigation of the optic nerves in 6 patients
with Leber’s hereditary optic neuropathy (LHON) receiving
idebenone and 9 LHON patients not receiving idebenone by
means of a Zero Echo Time (ZET) 7T MRI sequence with
an Adiabatic Spectral Inversion Recovery (ASPIR) fat suppression
pulse (silent-MT 7T-MRI) [1]. It was concluded
that the technique confirms known pathology of the optic
nerve in LHON [1]. We have the following comments and
concerns.
We disagree with the notion that ‘LHON is a disorder of
the optic nerve. LHON is pirmarely a disorder of the retinal
ganglion cells (RGCs), which is why it can be diagnosed by
the ophthalmologist. Secondarily, LHON affects dendrites
and axons of RGCs resulting in asymmetric optic atrophy.
There are no striking conclusions from this study. The
only results were that the silent-MT at 7T depicts the optic
nerve with high quality and artefact-free, that quantitative
measures of the optic nerve can be obtained, and that
LHON optic nerves showed focal hyperintensities.
The authors do not differentiate b etween L HON and
LHON plus [2]. LHON exclusively affects t he retina,
whereas LHON plus is characterised by multiorgan involvement,
affecting i n p articular t he e yes b ut a lso t he brain,
endocrine organs, bone marrow, arteries, kidneys, peripheral
nerves, and the heart [2]. We should know how many
of the included patients had LHON and how many LHON
plus. This is crucial as it may determine the outcome of
these patients [3].

KEYWORDS:

 Special Issue

Article Metrics Graph

Chart Graph | Range Graph

Content

Part of special issue:

Innovative Journal of Medical and Health Science

Article Metrics by Journal Systems

  • Citations not available
  • Readers 290
  • Download 135

  • Altmetric Attention score:
Altmetric badge

Share this article

Section

Source

  • How to Cite
  • [1]
    Josef Finsterer, MD, PhD*, “Assessing the effect of idebenone in LHON by silent-MT 7T-MRI of the optic nerve requires appropriate study designs”, ijmhs, vol. 10, no. 06, pp. 918–919, Jun. 2020.
    More Citation Formats
    ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
    Download Citation
    Endnote/Zotero/Mendeley (RIS) BibTeX
  • Issue Vol. 10 No. 06 (2020): Innovative Journal of Medical and Health Science
  • Section Research Articles

License

All paper submissions must carry the following duly signed by all the authors:
“I certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.”

Most read articles by the same author(s)

  • Josef Finsterer, MD, PhD*, POLG1 phenotypes may worsen rather from valproic acid and lidocaine than borreliosis or ceftriaxone , Innovative Journal of Medical and Health Sciences: Vol. 10 No. 06 (2020): Innovative Journal of Medical and Health Science
  • Josef Finsterer, MD, PhD*, Monitoring of outer retinal atrophy in maternally inherited diabetes and deafness by optical coherence tomogrpahy , Innovative Journal of Medical and Health Sciences: Vol. 10 No. 06 (2020): Innovative Journal of Medical and Health Science
  • Josef Finsterer, MD, PhD*, Pathogenicity of the variant m.15990C>T in progressive external ophthalmoplegia remains unproven , Innovative Journal of Medical and Health Sciences: Vol. 10 No. 06 (2020): Innovative Journal of Medical and Health Science
  • Josef Finsterer, MD, PhD*, Electrophysiology of LHON eyes may strongly depend on genetics, drugs, and multisystem involvement , Innovative Journal of Medical and Health Sciences: Vol. 10 No. 06 (2020): Innovative Journal of Medical and Health Science

Journal Information

  • Home
  • Editorial Board
  • Current Issue
  • Archive

Guidelines

  • Authorship Criteria
  • Reviewers Guidelines
  • Editorial Policy
  • Copyright Policy

Policies

  • Authorship Criteria
  • Reviewers Guidelines
  • Editorial Policy
  • Copyright Policy

Contact Us

  • Phone:(+91) 7566119900
  • Address:93 Divya Vihar, Near Rawati Range, Indore India
  • Website:www.innovativejournal.in

More information about the publishing system, Platform and Workflow by OJS/PKP.

Copyright © 2022 Innovative Journal of Medical and Health Sciences. All Rights Reserved

Published By: Innovative Journals